Display options
Share it on

BBA Clin. 2015 Jun 01;3:135-140. doi: 10.1016/j.bbacli.2015.01.002.

Secretion of salivary statherin is compromised in uncontrolled diabetic patients.

BBA clinical

Masahiro Izumi, Bin-Xian Zhang, David D Dean, Alan L Lin, Michèle J Saunders, Helen P Hazuda, Chih-Ko Yeh

Affiliations

  1. Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA.
  2. Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA.
  3. Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA.
  4. Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA ; Geriatric Research Education and Clinical Center (GRECC), South Texas Veterans Healthcare System, San Antonio, TX, 78229-4404, USA.

PMID: 25793156 PMCID: PMC4360915 DOI: 10.1016/j.bbacli.2015.01.002

Abstract

BACKGROUND: Statherin is an important salivary protein for maintaining oral health. The purpose of the current study was to determine if differences in statherin levels exist between diabetic and healthy subjects.

METHODS: A total of 48 diabetic and healthy controls were randomly selected from a community-based database. Diabetic subjects (n=24) had fasting glucose levels >180 mg/dL, while controls (n=24) had levels <110 mg/dL. Parotid saliva (PS) and sublingual/submandibular saliva (SS) were collected and salivary flow rates determined. Salivary statherin levels were determined by densitometry of Western blots. Blood hemoglobin A1c (HbA1c) and total protein in saliva were also obtained.

RESULTS: SS, but not PS, salivary flow rate and total protein in diabetics were significantly less than in healthy controls (p=0.021 & p<0.001 respectively). Correlation analysis revealed the existence of a negative correlation between PS statherin levels and HbA1c (p=0.012) and fasting glucose (p=0.021) levels, while no such correlation was found for SS statherin levels. When statherin levels were normalized to total salivary protein, the proportion of PS statherin, but not SS statherin, in diabetics was significantly less than controls (p=0.032). In contrast, the amount of statherin secretion in SS, but not PS, was significantly decreased in diabetics compared to controls (p=0.016).

CONCLUSIONS AND GENERAL SIGNIFICANCE: The results show that synthesis and secretion of statherin is reduced in diabetics and this reduction is salivary gland specific. As compromised salivary statherin secretion leads to increased oral health risk, this study indicates that routine oral health assessment of these patients is warranted.

Keywords: Diabetes; Oral health; Saliva; Statherin

References

  1. Arch Oral Biol. 2009 Jan;54(1):91-100 - PubMed
  2. Oral Dis. 2011 Oct;17(7):685-9 - PubMed
  3. Arch Oral Biol. 2004 May;49(5):379-85 - PubMed
  4. Eur J Oral Sci. 1996 Aug;104(4 ( Pt 1)):346-52 - PubMed
  5. Exp Diabetes Res. 2012;2012:947304 - PubMed
  6. J Proteome Res. 2013 Apr 5;12(4):1700-9 - PubMed
  7. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Mar;89(3):305-11 - PubMed
  8. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jul;86(1):69-76 - PubMed
  9. J Oral Pathol Med. 2015 Apr;44(4):291-5 - PubMed
  10. Am J Med Sci. 2013 Apr;345(4):271-3 - PubMed
  11. Oral Dis. 2011 Mar;17(2):217-20 - PubMed
  12. J Dent (Tehran). 2010 Winter;7(1):13-8 - PubMed
  13. J Oral Sci. 2010 Sep;52(3):359-68 - PubMed
  14. J Diabetes Complications. 2011 May-Jun;25(3):183-6 - PubMed
  15. Lab Invest. 2012 Jun;92 (6):868-82 - PubMed
  16. Biomed Chromatogr. 2005 Apr;19(3):214-22 - PubMed
  17. Nat Rev Endocrinol. 2011 Nov 08;8(4):228-36 - PubMed
  18. Arch Oral Biol. 2013 May;58(5):451-8 - PubMed
  19. Biochem Biophys Res Commun. 1991 Oct 15;180(1):91-7 - PubMed
  20. Behav Res Methods. 2009 Nov;41(4):1149-60 - PubMed
  21. J Dent Res. 1994 Dec;73(12):1811-7 - PubMed
  22. Oral Dis. 2005 Mar;11(2):95-9 - PubMed
  23. Community Dent Oral Epidemiol. 2000 Oct;28(5):373-81 - PubMed
  24. J Oral Pathol Med. 2010 Oct;39(9):715-21 - PubMed
  25. Protein Expr Purif. 2010 Feb;69(2):219-25 - PubMed
  26. Oral Dis. 2012 May;18(4):360-4 - PubMed
  27. Int J Exp Pathol. 2009 Aug;90(4):412-22 - PubMed
  28. Behav Res Methods. 2007 May;39(2):175-91 - PubMed
  29. Differentiation. 2012 Jan;83(1):68-76 - PubMed
  30. Aust Dent J. 2012 Jun;57(2):114-22 - PubMed
  31. J Oral Pathol Med. 1989 Oct;18(9):520-4 - PubMed

Publication Types

Grant support